Prevention of Radiochemotherapy-Induced Esophagitis With Glutamine: Results of a Pilot Study

The use of oral glutamine may have an important role in the prevention of esophageal complications of concomitant radiochemotherapy in lung cancer patients. However, randomized trials are needed to corroborate that effect. V50 is the dosimetric parameter with better correlation with esophagitis grade and duration.